Patents by Inventor Richard Einstein

Richard Einstein has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20120141376
    Abstract: Genes that are up regulated in human prostate tumor tissues and the corresponding proteins are identified. These genes and the corresponding antigens are suitable targets for the treatment, diagnosis or prophylaxis of prostate cancer.
    Type: Application
    Filed: June 29, 2007
    Publication date: June 7, 2012
    Inventors: Richard Einstein, Kevin Paul Kane, Matthew Paul Pando
  • Patent number: 7834163
    Abstract: Genes that are upregulated in human prostate tumor tissues and the corresponding proteins are identified. These genes and the corresponding antigens are suitable targets for the treatment, diagnosis or prophylaxis of prostate cancer.
    Type: Grant
    Filed: June 25, 2004
    Date of Patent: November 16, 2010
    Assignee: Exonhit Therapeutics S.A.
    Inventors: Richard Einstein, Kevin M. McGowan, Matthew P. Pando
  • Publication number: 20080254031
    Abstract: Genes and variant RNAs that are differentially expressed in human colon tumor tissues compared with normal colon tissue and the corresponding proteins are identified. These genes and the corresponding antigens are suitable targets for the treatment, diagnosis or prophylaxis of colon cancer.
    Type: Application
    Filed: September 7, 2005
    Publication date: October 16, 2008
    Applicant: EXONHIT THERAPEUTICS SA
    Inventors: Kevin McGowan, Vinayaka Kotraiah, Michael Brenner, Richard Einstein, Laurent Bracco
  • Publication number: 20060115821
    Abstract: Genes that are upregulated in human prostate tumor tissues and the corresponding proteins are identified. These genes and the corresponding antigens are suitable targets for the treatment, diagnosis or prophylaxis of prostate cancer.
    Type: Application
    Filed: June 25, 2004
    Publication date: June 1, 2006
    Inventors: Richard Einstein, Kevin McGowan, Matthew Pando
  • Publication number: 20040101818
    Abstract: The present invention identifies genes whose expression pattern is altered when precursor stem cells undergo differentiation into osteoblasts. The genes identified may be used as markers for the differentiation process. The present invention also provides methods to screen agents that are capable of modulating the differentiation process. The present invention also provides methods of identifying therapeutic agents that stimulate bone information by analyzing the expression of one or more of the genes identified.
    Type: Application
    Filed: December 16, 2003
    Publication date: May 27, 2004
    Inventors: Darren Ji, Douglas W. Axelrod, Jonathan S. Cook, Neelam Jaiswal, Richard Einstein, Adam Houghton, Lawrence Mertz
  • Publication number: 20030166881
    Abstract: The invention relates generally to the changes in gene expression in mast cells during maturation and in tissues removed from patients with urticaria or allergic hypersensitivity relative to gene expression in mast cells removed from normal subjects. The invention specifically relates to four novel gene families which are differentially expressed in mast cells and allergic hypersensitivity diseases, such as urticaria, compared to normal tissues.
    Type: Application
    Filed: December 7, 2001
    Publication date: September 4, 2003
    Inventors: Karl Nocka, Gregorio Pirozzi, Richard Einstein